LongeVC
Actively deployingNewark
Fund manager profile
LongeVC is a venture fund manager based in Newark. SEC filings show 1 venture fund on record, most recently LongeVC Fund II, LP filed November 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 3 of 3 portfolio companiesBiotech Γ3Healthtech Γ3Medical Devices Γ3AI & Machine Learning Γ2Deep Tech Γ1Digital Health Γ1
HQs:United StatesΓ3
Investments Β· 3 tracked
founders shown can be your intro pathAOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana(CEO)AlexAnna(Chief Regulatory Officer)<UNKNOWN>
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors. The company's technology enables therapeutic structures that deliver dual payloads to cancer targets.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Frequently asked questions
- Where is LongeVC located?
- LongeVC is headquartered in Newark, US.